• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟雾病患者外周血中的基因失调及其与其他血管疾病的比较。

Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders.

机构信息

CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.

University of Chinese Academy of Sciences, Beijing, China.

出版信息

PLoS One. 2019 Sep 18;14(9):e0221811. doi: 10.1371/journal.pone.0221811. eCollection 2019.

DOI:10.1371/journal.pone.0221811
PMID:31532776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6750579/
Abstract

OBJECTIVE

Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with unknown etiology, sharing many similar clinical symptoms with other vascular disorders. This study aimed to investigate gene dysregulation in peripheral blood of MMD and compare it with other vascular disorders.

METHODS

Transcriptomic profiles of 12 MMD patients and 8 healthy controls were obtained using RNA sequencing. Differentially expressed genes (DEGs) were identified and several were validated by quantitative real-time PCR in independent samples. Biological pathway enrichment analysis of DEGs and deconvolution of leukocyte subsets in peripheral blood were performed. Expression profiles for other vascular diseases were downloaded from public database and consistent DEGs were calculated. Gene set enrichment analysis (GSEA) was conducted to compare gene dysregulation pattern between MMD and other vascular diseases.

RESULTS

A total of 533 DEGs were identified for MMD. Up-regulated genes were mainly involved in extracellular matrix (ECM) organization, whereas down-regulated genes were primarily associated with inflammatory and immune responses. As for cell populations, significantly increased naïve B cells and naïve CD4 cells as well as obviously decreased resting natural killer cells were observed in peripheral blood of MMD patients. GSEA analysis indicated that only up-regulated genes of ischemic stroke and down-regulated genes of coronary artery disease and myocardial infarction were enriched in up-regulated and down-regulated genes of MMD, respectively.

CONCLUSION

Dysregulated genes in peripheral blood of MMD mainly played key roles in ECM organization, inflammatory and immune responses. This gene dysregulation pattern was specific compared with other vascular diseases. Besides, naïve B cells, naïve CD4 cells and resting natural killer cells were aberrantly disrupted in peripheral blood of MMD patients. These results will help elucidate the complicated pathogenic mechanism of MMD.

摘要

目的

烟雾病(MMD)是一种病因不明的慢性闭塞性脑血管病,与其他血管疾病有许多相似的临床症状。本研究旨在探讨 MMD 患者外周血中的基因失调,并与其他血管疾病进行比较。

方法

采用 RNA 测序技术获取 12 例 MMD 患者和 8 例健康对照者的转录组谱。鉴定差异表达基因(DEGs),并在独立样本中通过定量实时 PCR 验证部分基因。对 DEGs 进行生物通路富集分析,并对外周血中的白细胞亚群进行反卷积分析。从公共数据库中下载其他血管疾病的表达谱,计算一致的 DEGs。进行基因集富集分析(GSEA)比较 MMD 与其他血管疾病之间的基因失调模式。

结果

共鉴定出 533 个与 MMD 相关的 DEGs。上调基因主要参与细胞外基质(ECM)组织,而下调基因主要与炎症和免疫反应有关。对于细胞群体,MMD 患者外周血中幼稚 B 细胞和幼稚 CD4 细胞明显增加,静止自然杀伤细胞明显减少。GSEA 分析表明,只有缺血性卒中的上调基因和冠心病及心肌梗死的下调基因在 MMD 的上调和下调基因中分别富集。

结论

MMD 患者外周血中失调的基因主要参与 ECM 组织、炎症和免疫反应。与其他血管疾病相比,这种基因失调模式具有特异性。此外,MMD 患者外周血中的幼稚 B 细胞、幼稚 CD4 细胞和静止自然杀伤细胞异常失调。这些结果将有助于阐明 MMD 复杂的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/baf49e4a5953/pone.0221811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/d598ce4d0c12/pone.0221811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/2a1c08b6f90b/pone.0221811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/be243729b7c8/pone.0221811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/4f75e924c0b7/pone.0221811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/baf49e4a5953/pone.0221811.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/d598ce4d0c12/pone.0221811.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/2a1c08b6f90b/pone.0221811.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/be243729b7c8/pone.0221811.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/4f75e924c0b7/pone.0221811.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/6750579/baf49e4a5953/pone.0221811.g005.jpg

相似文献

1
Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders.烟雾病患者外周血中的基因失调及其与其他血管疾病的比较。
PLoS One. 2019 Sep 18;14(9):e0221811. doi: 10.1371/journal.pone.0221811. eCollection 2019.
2
Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.来源于烟雾病诱导多能干细胞的血管平滑肌细胞——与血管内皮细胞转录组的比较特征分析。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105305. doi: 10.1016/j.jstrokecerebrovasdis.2020.105305. Epub 2020 Sep 23.
3
Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis.基于生物信息学分析鉴定脑烟雾病免疫浸润的枢纽基因作为潜在的生物标志物。
Orphanet J Rare Dis. 2022 Feb 23;17(1):80. doi: 10.1186/s13023-022-02238-4.
4
LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation.与 RNF213 突变无关的烟雾病患者血管重构相关的长链非编码 RNA-mRNA 共表达谱。
World Neurosurg. 2022 Feb;158:e880-e888. doi: 10.1016/j.wneu.2021.11.104. Epub 2021 Nov 27.
5
Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic Moyamoya disease.环状 RNA 谱分析中性粒细胞转录组可深入了解无症状性烟雾病。
Brain Res. 2019 Sep 15;1719:104-112. doi: 10.1016/j.brainres.2019.05.033. Epub 2019 May 24.
6
Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease.脑底异常血管网病患者 lncRNA-mRNA 共表达谱的综合分析。
Sci Rep. 2017 Feb 8;7:42421. doi: 10.1038/srep42421.
7
Characterization of PANoptosis-related genes and the immune landscape in moyamoya disease.PANoptosis 相关基因特征及在烟雾病中的免疫图谱
Sci Rep. 2024 May 4;14(1):10278. doi: 10.1038/s41598-024-61241-w.
8
Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease.长链非编码RNA及其调控网络:成人烟雾病的潜在治疗靶点
World Neurosurg. 2016 Sep;93:111-9. doi: 10.1016/j.wneu.2016.05.081. Epub 2016 Jun 4.
9
Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model.从烟雾病患者中分离出的平滑肌祖细胞:新型实验细胞模型。
J Neurosurg. 2014 Feb;120(2):415-25. doi: 10.3171/2013.9.JNS131000. Epub 2013 Oct 25.
10
Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.富含血脑屏障的外泌体蛋白质组学分析及血管内皮细胞中线粒体功能障碍在出血性烟雾病中的作用
Stroke. 2021 Oct;52(10):3351-3361. doi: 10.1161/STROKEAHA.120.032297. Epub 2021 Aug 2.

引用本文的文献

1
Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease.全基因组DNA甲基化分析揭示烟雾病中甲基化变异性较低
Transl Stroke Res. 2024 Oct 2. doi: 10.1007/s12975-024-01299-w.
2
Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease.脑底异常血管网病患者循环免疫细胞图谱和 T 细胞异常。
Clin Transl Med. 2024 Apr;14(4):e1647. doi: 10.1002/ctm2.1647.
3
Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease.

本文引用的文献

1
ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease.烟雾病患者的ST段抬高型心肌梗死(STEMI)
Case Rep Cardiol. 2019 Feb 4;2019:7124072. doi: 10.1155/2019/7124072. eCollection 2019.
2
Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based.基于心理神经内分泌免疫学的冠心病中的应激与炎症:综述
Front Immunol. 2018 Sep 6;9:2031. doi: 10.3389/fimmu.2018.02031. eCollection 2018.
3
Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism.
质谱细胞术揭示了不同 Suzuki 期烟雾病患者循环免疫细胞图谱。
Immunol Res. 2024 Aug;72(4):654-664. doi: 10.1007/s12026-024-09464-x. Epub 2024 Feb 20.
4
GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease.GM-CSF 促进烟雾病中功能失调的血管网络的发展。
Neurosci Bull. 2024 Apr;40(4):451-465. doi: 10.1007/s12264-023-01158-y. Epub 2023 Dec 19.
5
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.烟雾病及相关血管疾病中血管生成与炎症的分子和细胞生物学的生理及病理生理机制
Front Neurol. 2023 May 16;14:661611. doi: 10.3389/fneur.2023.661611. eCollection 2023.
6
RNA profiling of sEV (small extracellular vesicles)/exosomes reveals biomarkers and vascular endothelial dysplasia with moyamoya disease.sEV(小细胞外囊泡)/外泌体的 RNA 分析显示,烟雾病伴有血管内皮发育不良的生物标志物。
J Cereb Blood Flow Metab. 2023 Jul;43(7):1194-1205. doi: 10.1177/0271678X231162184. Epub 2023 Mar 8.
7
Transradial Access Failures During Neuroangiography for Patients With Moyamoya.经桡动脉入路在烟雾病患者神经血管造影中的失败。
Neurosurgery. 2023 Aug 1;93(2):366-372. doi: 10.1227/neu.0000000000002421. Epub 2023 Feb 27.
8
Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy.儿童烟雾病患者循环内皮祖细胞和释放的血管生成因子增加。
Int J Mol Sci. 2023 Jan 8;24(2):1233. doi: 10.3390/ijms24021233.
9
ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data.ReDisX是一种机器学习方法,通过从类风湿性关节炎和冠状动脉疾病患者的基因组数据中识别亚群分化标志物,对这些患者进行独特的分析。
Front Med (Lausanne). 2022 Aug 22;9:931860. doi: 10.3389/fmed.2022.931860. eCollection 2022.
10
Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis.烟雾病成年患者颅内动脉的转录组分析揭示了其发病机制的新见解。
Front Mol Neurosci. 2022 May 31;15:881954. doi: 10.3389/fnmol.2022.881954. eCollection 2022.
炎症、氧化和代谢生物标志物预测冠心病发病风险。
Sci Rep. 2018 Feb 16;8(1):3191. doi: 10.1038/s41598-018-21482-y.
4
Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.脑烟雾病患者血清可溶性 CD163 和 CXCL5 水平升高:固有免疫反应参与其发病机制。
Brain Res. 2018 Jan 15;1679:39-44. doi: 10.1016/j.brainres.2017.11.013. Epub 2017 Nov 22.
5
Inflammatory biomarkers of coronary heart disease.冠心病的炎症生物标志物。
Front Biosci (Schol Ed). 2018 Jan 1;10(1):185-196. doi: 10.2741/s508.
6
The frontline of immune response in peripheral blood.外周血中免疫反应的前沿。
PLoS One. 2017 Aug 3;12(8):e0182294. doi: 10.1371/journal.pone.0182294. eCollection 2017.
7
Association of increased Treg and Th17 with pathogenesis of moyamoya disease.调节性 T 细胞和 Th17 细胞增加与烟雾病发病机制的关联。
Sci Rep. 2017 Jun 8;7(1):3071. doi: 10.1038/s41598-017-03278-8.
8
GSA: Genome Sequence Archive<sup/>.GSA:基因组序列档案库。
Genomics Proteomics Bioinformatics. 2017 Feb;15(1):14-18. doi: 10.1016/j.gpb.2017.01.001. Epub 2017 Feb 2.
9
Moyamoya and Inflammation.烟雾病与炎症
World Neurosurg. 2017 Apr;100:575-578. doi: 10.1016/j.wneu.2017.01.012. Epub 2017 Jan 16.
10
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.RNF213 作为中国烟雾病患者的主要易感基因及其临床相关性。
J Neurosurg. 2017 Apr;126(4):1106-1113. doi: 10.3171/2016.2.JNS152173. Epub 2016 Apr 29.